Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography

Description

Global Biosimulation Market is expected to reach US$ 5,894.4 Mn by 2030, from US$ 1,901.9 Mn in 2023, exhibiting a CAGR of 17.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 1,901.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	17.50%	2030/2031 Value Projection:	US$ 5,894.4 Mn

Figure 1. Global Biosimulation Market Share (%), By Region, 2023

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics:

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study:

This report provides in-depth analysis of the global biosimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Biosimulation Market Detailed Segmentation:

By Product and Services
- Software
- Services
By Application
- Drug Discovery
- Drug Development
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Top companies in Global Biosimulation Market
- Certara, L.P.
- Simulations Plus, Inc.
- Dassault Systemes (Accelrys)
- Genedata AG
- LeadScope, Inc.
- Compugen Inc.
- Schrodinger, LLC
- In Silico Biosciences, Inc.
- Advanced Chemistry Development, Inc.
- Chemical Computing Group ULC
- Physiomics PLC
- Pharmaceutical Product Development, LLC (Evidera)

Product Code: CMI2016

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biosimulation Market Snippet, By Product and Services
- Global Biosimulation Market Snippet, By Application
- Global Biosimulation Market Snippet, By Distribution Channel
- Global Biosimulation Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Biosimulation Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Biosimulation Market, By Product and Services, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Biosimulation Market, By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Biosimulation Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Biosimulation Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Simulations Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dassault Systemes (Accelrys)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
LeadScope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Compugen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Schrodinger, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
In Silico Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Advanced Chemistry Development, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chemical Computing Group ULC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Physiomics PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pharmaceutical Product Development, LLC (Evidera)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us